Showing results (1-10 of 488) with videos related to
Sort By:
Pageof 49
Neuroreport|November 26, 1999
D3 receptor knockdown through antisense oligonucleotide administration supports its inhibitory role in locomotionL B Menalled, G Dziewczapolski, M C Garcia, et al.Current Opinion in Neurology and Neurosurgery|June 1, 1993
Drug-induced movement disordersO S GershanikDrugs & Aging|August 1, 1994
Drug-induced parkinsonism in the aged. Recognition and preventionO S GershanikNeuroreport|May 20, 1998
Opposite roles of D1 and D5 dopamine receptors in locomotion revealed by selective antisense oligonucleotidesG Dziewczapolski, L B Menalled, M C García, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1997
Threshold of dopamine content and D1 receptor stimulation necessary for the expression of rotational behavior induced by D2 receptor stimulation under normo and supersensitive conditionsG Dziewczapolski, M A Mora, L B Menalled, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Orthostatic tremor: an essential tremor variant?S M Papa, O S GershanikMovement Disorders : Official Journal of the Movement Disorder Society|July 1, 1993
Modulatory effect of clozapine on levodopa response in Parkinson's disease: a preliminary studyG J Arevalo, O S GershanikJournal of Neural Transmission. Supplementum|January 1, 1988
Lisuride infusion pump in Parkinson's disease. A report of two casesO S Gershanik, O Scipioni, S GarcíaMovement Disorders : Official Journal of the Movement Disorder Society|July 1, 1995
Cervical dystonia due to spinal cord ependymoma: involvement of cervical cord segments in the pathogenesis of dystoniaA Cammarota, O S Gershanik, S García, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Isoniazid therapy in Parkinson's diseaseO S Gershanik, M R Luquin, O Scipioni, et al.Pageof 49